VITASPRING BIOMEDICAL CO., LTD. Accumulated Capitalized Interest Costs
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Accumulated Capitalized Interest Costs of $101.55 thousand as of 2020-10-31, per its 10-Q filed 2020-12-15.
Discontinued › Notes › Debt
us-gaap:AccumulatedCapitalizedInterestCosts · last filed 2020-12-15
- 2020-10-31: Accumulated Capitalized Interest Costs $101.55K.
| Period end | Accumulated Capitalized Interest Costs |
|---|---|
| 2020-10-31 | $101.55K 10-Q · filed 2020-12-15 |